MRI Bone Marrow Signal

Why marrow signal matters. Bone marrow signal is one of the most clinically important findings in orthopaedic MRI. A change in marrow signal allows early diagnosis of occult fractures, stress injuries, avascular necrosis, infection and tumour infiltration, often weeks or months before any of them is visible on plain radiographs or CT.

The T1 principle. Normal adult marrow is predominantly yellow (fatty), and fat has a short T1, so normal marrow is bright on T1-weighted images. Any process that replaces, displaces or alters that fat reduces the T1 signal, and the abnormal area reads darker than the normal marrow around it. The question is the marrow bright or dark on T1? is the single most important assessment in musculoskeletal MRI.

View larger

What they are. Modic changes are vertebral endplate and subchondral marrow signal changes associated with degenerative disc disease, classified into three types by their MRI signal characteristics.

They are stages, not categories, and knowing the direction of travel explains the clinical picture. In Modic's original longitudinal follow-up, Type 1 changes converted to Type 2 in five of six patients over fourteen months to three years, while Type 2 changes remained stable over two to three years. That single observation accounts for most of what is otherwise puzzling about Modic changes: Type 1 is a transitional, actively inflammatory state, which is why it correlates with pain and why it is the type that gets better on its own; Type 2 is the settled endpoint, which is why it is the commonest type seen on any given scan and why it correlates poorly with symptoms. A Type 1 change on a scan taken today is unlikely to still be Type 1 in three years.

Type 3 is sclerotic bone with no free water or fat, so it is dark on T1, T2 and STIR alike: the least common type and the end-stage change.

Type 1 in the clinic. Type 1 is the most clinically significant type because it represents active inflammation and is most strongly associated with axial back pain. It may also indicate low-grade infection: Type 1 change can be an early sign of discitis or osteomyelitis and must be interpreted in clinical context. Over time it may progress to Type 2 (fatty) or may persist and remain symptomatic; whether persistent Type 1 change should be treated with antibiotics is taken up under Controversies.

View larger

View larger

Read the marrow in a fixed order. Six steps, each with the question it answers; the T1 comparison with muscle is the first.

View larger

The T1 rule. Compare the marrow with the adjacent skeletal muscle on T1. Normal marrow is brighter than muscle, and marrow that is darker than muscle is abnormal and needs further evaluation, because a T1 signal that falls below muscle indicates oedema, infection, tumour infiltration or fibrosis. Physiological red marrow reconversion is not on that list: however extensive it is, reconverted marrow stays at or above muscle, which is precisely why the comparison with muscle works as a discriminator. This one rule catches the majority of significant marrow pathology.

The patterns. With the T1 signal placed against muscle, the T1, T2 and STIR behaviour together sort an abnormality into one of five patterns:

• Oedema - T1 dark, STIR bright (fracture, infection, tumour, reactive change)
• Infiltration - T1 dark, may enhance with gadolinium (tumour, leukaemia, lymphoma)
• Fatty replacement - T1 bright, STIR suppressed (chronic change, a healed process)
• Fibrosis or sclerosis - dark on T1 and T2, low signal on all sequences (Paget disease, chronic osteomyelitis, radiation therapy)
• Red marrow reconversion - slightly dark on T1, often symmetric and in expected locations (a physiological response to anaemia, chronic illness, smoking)

View larger

Normal conversion. At birth the entire skeleton contains red (haematopoietic) marrow. Through childhood and adolescence it converts to yellow (fatty) marrow in a predictable order: distal to proximal, so the feet and hands go first and the axial skeleton last, and within each long bone from diaphysis to metaphysis. By approximately age 25 the adult pattern is reached, with red marrow confined to the axial skeleton, the proximal femora, the proximal humeri and some metaphyseal regions. Yellow marrow is T1 bright; red marrow is less bright but still usually brighter than muscle.

Why the sequence matters. Residual red marrow in children, adolescents and young adults may mimic pathology, and knowing the normal order of conversion is what avoids the misdiagnosis.

Reconversion. Under certain physiological and pathological conditions yellow marrow can reconvert to red marrow, and it does so in the reverse pattern: proximal to distal, metaphysis to diaphysis. Reconversion increases the proportion of red (haematopoietic) marrow at the expense of yellow (fatty) marrow, and the practical problem is that reconverted marrow can be mistaken for infiltration. The table separates them.

View larger

View larger

The examination scenario. The commonest one is a marrow signal abnormality where the candidate must generate and prioritise a differential. The decisive variables are the T1 signal relative to muscle, the STIR/T2 behaviour, the distribution, and the presence of an associated fracture line, mass or soft-tissue component.

View larger

View larger

Diffusion-weighted and whole-body MRI. Beyond conventional T1/STIR, diffusion-weighted imaging (DWI) is now central to assessing diffuse marrow disease (myeloma, metastatic infiltration). Highly cellular tumour restricts water diffusion, so it remains bright at high b-values with a low apparent diffusion coefficient (ADC), whereas normal fatty and benign red marrow do not. Whole-body MRI (T1 plus STIR plus DWI from skull to mid-thigh) is recommended by myeloma guidelines (IMWG): it detects focal and diffuse marrow infiltration earlier than skeletal survey, and more than one focal marrow lesion on whole-body MRI is itself a myeloma-defining event. Myeloma marrow has recognised patterns: normal, focal, diffuse, "variegated" or salt-and-pepper, and combined.

A caveat for treatment monitoring. Effective therapy can paradoxically raise the ADC (tumour necrosis and liquefaction), so falling cellularity is interpreted alongside the conventional sequences, and ADC response thresholds remain incompletely standardised.

Across every major examination system, MRI is regarded as the investigation of choice for suspected occult fracture, stress injury, avascular necrosis, osteomyelitis and marrow infiltration, because bone marrow signal change precedes radiographic change by weeks to months. The cardinal principle — loss of normal T1 fatty (bright) marrow signal — is universal and not country-specific.

Global epidemiology and registry context. Femoral neck fragility fractures number in the millions worldwide each year, and a meaningful minority are radiographically occult at presentation — the driver for rapid MRI access. National hip-fracture registries (for example the UK National Hip Fracture Database and equivalents in the Nordic countries, Australia and New Zealand) consistently link early definitive diagnosis and surgery to lower morbidity, which underpins the 24-hour MRI recommendation. Arthroplasty registries (NJR for England and Wales, AJRR in the US, AOANJRR in Australia, and the Swedish and Norwegian registries) report on osteonecrosis and periprosthetic bone quality as factors in revision, where MRI marrow signal informs pre-operative planning.

High- versus limited-resource practice variation. Where MRI is freely available it is the first advanced test for occult fracture, osteonecrosis and infection. In limited-resource or after-hours settings, CT is widely substituted for the occult hip fracture (it detects most though not all non-displaced fractures), and a delayed repeat radiograph at 10-14 days or a technetium bone scan may be used when cross-sectional imaging is inaccessible. For marrow infiltration and myeloma, diffusion-weighted whole-body MRI is expanding in high-resource centres but skeletal survey or low-dose whole-body CT remains the practical alternative elsewhere.

Antibiotics for Modic Type 1 change. The hypothesis that some Modic Type 1 changes reflect low-virulence disc infection (notably Cutibacterium acnes) led to trials of prolonged oral antibiotics for chronic low back pain, and some authors have advocated antibiotic treatment for persistent Type 1 changes that fail to respond to conservative management (the Modic Antibiotic Spine Therapy concept). Early results were promising, but later, better-controlled studies and meta-analyses have been inconsistent, and concerns about antibiotic stewardship persist. Routine antibiotic therapy for Modic Type 1 change is not standard practice and remains investigational.

Occult hip fracture: MRI versus CT. MRI is the most sensitive test for the occult hip fracture, but multidetector CT detects most non-displaced fractures and is faster and cheaper, and debate continues over whether CT is an adequate first-line substitute. The pragmatic global position is MRI first where available within 24 hours, with CT reserved for when MRI is contraindicated, not tolerated or unavailable, accepting a small false-negative rate for CT.

Defining pathological marrow oedema. 'Bone marrow oedema' on STIR is sensitive but profoundly non-specific: subchondral bone marrow lesions in osteoarthritis, post-traumatic contusion, reactive change adjacent to enthesopathy and early infection can look similar. The term 'bone marrow oedema-like signal' is preferred because true interstitial oedema is only one of several histological substrates, which also include necrosis, fibrosis and marrow fat loss.

Whole-body and diffusion-weighted MRI. Diffusion-weighted whole-body MRI is increasingly used for myeloma and metastatic marrow disease, but protocol standardisation and access remain unsettled, especially outside specialist centres.